Abstract: Hepatitis C virus inhibitors are disclosed having the general formula: wherein R1, R2, R3, R?, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Type:
Grant
Filed:
November 18, 2004
Date of Patent:
December 18, 2007
Assignee:
Birstol-Myers Squibb Company
Inventors:
Yong Tu, Paul Michael Scola, Andrew Charles Good, Jeffrey Allen Campbell